Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-13

FDA Approved: NISOLDIPINE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a supplemental application for Nisoldipine submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nisoldipine (Nisoldipine)

Snippet

SUPPL AP for NISOLDIPINE (NISOLDIPINE)